The US healthcare system’s focus on activity rather than value for money was behind the demise of Proteus Digital Health and its “digital pill”, which measured whether schizophrenia patients ...

Otsuka has reportedly acquired the full licence for the adherence technology, leaving Proteus to focus on using the technology in cancer and infectious diseases. But these plans are in serious ...